Literature DB >> 23323895

Should blood be an essential medicine?

Harvey G Klein1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23323895     DOI： 10.1056/NEJMp1213134

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Red blood cell components: time to revisit the sources of variability.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

2.  Transfusion of Blood Products in the Neurocritical Care Unit: An Exploration of Rationing and Futility.

Authors:  Deepa P Malaiyandi; Galen V Henderson; Michael A Rubin
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

Review 3.  Does prolonged storage of red blood cells cause harm?

Authors:  Willy A Flegel; Charles Natanson; Harvey G Klein
Journal:  Br J Haematol       Date:  2014-01-25       Impact factor: 6.998

4.  TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.

Authors:  Ming-Li Chou; Thierry Burnouf; Shun-Pang Chang; Ting-Chun Hung; Chun-Ching Lin; Christopher D Richardson; Liang-Tzung Lin
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 5.  “Go no Go” in plasma fractionation in the world’s emerging economies: still a question asked 70 years after the COHN process was developed!

Authors:  Thierry Burnouf; Jerard Seghatchian
Journal:  Transfus Apher Sci       Date:  2014-10       Impact factor: 1.764

Review 6.  Taking the bull by the horns: Ethical considerations in the design and implementation of an Ebola virus therapy trial.

Authors:  Francis Kombe; Morenike O Folayan; Jennyfer Ambe; Adaora Igonoh; Akin Abayomi
Journal:  Soc Sci Med       Date:  2015-11-30       Impact factor: 4.634

7.  Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.

Authors:  Andrew J Doyle; Anicee Danaee; Charlene I Furtado; Scott Miller; Tim Maggs; Susan E Robinson; Andrew Retter
Journal:  Br J Haematol       Date:  2020-10-21       Impact factor: 8.615
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.